Sign Out
Pregnancy: There is no indication for the use of Pergoveris during pregnancy. Data on a limited number of exposed pregnancies indicate no adverse reactions of follitropin alfa and lutropin alfa on pregnancy, embryonal or foetal development, parturition or postnatal development following controlled ovarian stimulation. No teratogenic effect of such gonadotropins has been reported in animal studies. In case of exposure during pregnancy, clinical data are not sufficient to exclude a teratogenic effect of Pergoveris.
Breast-feeding: Pergoveris is not indicated during breast-feeding.
Fertility: Pergoveris is indicated for use in infertility (see Indications/Uses).
